Biotech

All Articles

Life science credit report company reveals along with $600M

.A brand new worldwide life science credit score agency, referred to as Symbiotic Capital, has broug...

BMS channels TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another significant bet coming from the Caforio age, ending a dea...

Nuvation stops BET prevention after looking at stage 1 data

.After taking a look at stage 1 information, Nuvation Biography has decided to halt work on its own ...

' Clinical intuitiveness' led FDA consultants to back Zevra's unusual illness med

.Zevra Therapies' unusual ailment medication seems to become on the road to authorization this autum...

Pfizer takes $230M reached after axing neglected DMD genetics treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has actually blown a $230...

AC Immune finds 'spots' potential in Alzheimer's medicine records

.After much more than two decades of work with neurodegenerative conditions, Swiss biotech hvac Invu...

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class potential

.GSK has actually scrapped a period 2 human papillomavirus (HPV) vaccination coming from its own pip...

OS Treatments refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies are going to note on the NYSE American supply substitution this morning via a $6.4 mil...

ALX's fizzling CD47 feedback fee delivers sell spiraling down

.ALX Oncology's period 2 gastric cancer reaction fee has weakened. After viewing its CD47 blocker co...

Ionis axes eye health condition from intendeds of Roche-partnered possibility after records disappoint

.Another of Ionis Pharmaceuticals' essential midphase readouts has fallen short of expectations, tri...